Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An interview with J. Jaime Caro.

J Jaime Caro

    The American Journal of Managed Care
    |December 21, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Optimizing anticoagulation for patients with atrial fibrillation (AF) can significantly reduce stroke costs. This research highlights potential savings for healthcare systems and decision-makers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology.

    PharmacoEconomics·2026
    Same author

    Economic Evaluation of Pre-emptive Pharmacogenetic Panel Testing versus No Genetic Testing in a Multi-ethnic Asian Population.

    PharmacoEconomics·2026
    Same author

    Lowering the Barriers to the Appropriate Use of Individual-Level Simulation for Health Economic Evaluation.

    PharmacoEconomics·2026
    Same author

    Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease.

    Orphanet journal of rare diseases·2024
    Same author

    Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. <i>Cancers</i> 2023, <i>15</i>, 1812.

    Cancers·2023
    Same author

    Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore.

    Cancers·2023
    Same journal

    Prescription drug prior authorization: costs to pharmacies and physicians.

    The American journal of managed care·2026
    Same journal

    Combined pharmacotherapy and psychotherapy impact on opioid use disorder treatment.

    The American journal of managed care·2026
    Same journal

    The societal costs of food insecurity: implications for managed care strategies.

    The American journal of managed care·2026
    Same journal

    Availability of hospital financial assistance documents in non-English languages.

    The American journal of managed care·2026
    Same journal

    Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

    The American journal of managed care·2026
    Same journal

    Social needs screening and supplemental benefits in Medicare Advantage.

    The American journal of managed care·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Health Economics
    • Public Health

    Background:

    • Atrial fibrillation (AF) increases stroke risk, necessitating effective anticoagulation strategies.
    • The economic burden of stroke in AF patients is substantial and requires careful management.
    • Optimizing anticoagulation offers a potential avenue for cost savings in stroke prevention.

    Discussion:

    • This research analyzes the economic impact of stroke in AF patients.
    • It explores the financial benefits of improving anticoagulation therapies.
    • Findings are relevant for clinicians, researchers, and managed care decision-makers.

    Key Insights:

    • Implementing optimized anticoagulation can lead to significant cost reductions in stroke care.
    • Economic analyses provide crucial data for resource allocation in prevention programs.

    Related Experiment Videos

  • Early results were presented at the 2004 World Stroke Congress.

    • Outlook:

    • Further research can refine economic models for anticoagulation in AF.
    • Translating economic findings into clinical practice can improve patient outcomes and system efficiency.
    • This work informs policy regarding stroke prevention and resource allocation.